Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The oncologist

Showing results (11-20 of 6,676) with videos related to

Pageof 668
Sort By:
The Oncologist|February 23, 2011
A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negativeJigisha P Thakkar, Divyesh G Mehta
The Oncologist|February 25, 2011
Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combinationAndrés J M Ferreri, Giada Licata, Marco Foppoli, et al.
The Oncologist|February 25, 2011
New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overviewRobert J Motzer
The Oncologist|February 2, 2011
Factors associated with response to methylphenidate in advanced cancer patientsSriram Yennurajalingam, J Lynn Palmer, Ray Chacko, et al.
The Oncologist|December 15, 2010
Inhibitors of mTORHeinz-Josef Klümpen, Jos H Beijnen, Howard Gurney, et al.
The Oncologist|December 15, 2010
Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatmentRobert Grützmann, Marco Niedergethmann, Christian Pilarsky, et al.
The Oncologist|February 1, 2011
Chemotherapy: updates and new perspectivesSandra M Swain
The Oncologist|February 1, 2011
Directed therapy of subtypes of triple-negative breast cancerLisa A Carey
The Oncologist|January 25, 2011
What do prostate cancer patients die of?Matias Riihimäki, Hauke Thomsen, Andreas Brandt, et al.
The Oncologist|March 10, 2011
Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II studySabrina Witherby, Julia Johnson, Laurence Demers, et al.
Pageof 668

Showing results (11-20 of 6,676) with videos related to

Sort By:
Pageof 668
The Oncologist|February 23, 2011
A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negativeJigisha P Thakkar, Divyesh G Mehta
The Oncologist|February 25, 2011
Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combinationAndrés J M Ferreri, Giada Licata, Marco Foppoli, et al.
The Oncologist|February 25, 2011
New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overviewRobert J Motzer
The Oncologist|February 2, 2011
Factors associated with response to methylphenidate in advanced cancer patientsSriram Yennurajalingam, J Lynn Palmer, Ray Chacko, et al.
The Oncologist|December 15, 2010
Inhibitors of mTORHeinz-Josef Klümpen, Jos H Beijnen, Howard Gurney, et al.
The Oncologist|December 15, 2010
Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatmentRobert Grützmann, Marco Niedergethmann, Christian Pilarsky, et al.
The Oncologist|February 1, 2011
Chemotherapy: updates and new perspectivesSandra M Swain
The Oncologist|February 1, 2011
Directed therapy of subtypes of triple-negative breast cancerLisa A Carey
The Oncologist|January 25, 2011
What do prostate cancer patients die of?Matias Riihimäki, Hauke Thomsen, Andreas Brandt, et al.
The Oncologist|March 10, 2011
Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II studySabrina Witherby, Julia Johnson, Laurence Demers, et al.
Pageof 668